Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications
- PMID: 24057890
- DOI: 10.1007/s12031-013-0115-4
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications
Abstract
We studied the interaction of a single dose of different antidepressant medications with a single (acute) dose or implanted mini-pump (chronic) methadone administration in mice, using the hotplate assay. For the acute experiment, subthreshold doses of six antidepressant drugs were administered separately with a single dose of methadone. The addition of a subthreshold dose of desipramine or clomipramine to methadone produced significant augmentation of the methadone effect with each drug (p < 0.05). Fluvoxamine given at a fixed subthreshold dose induced a synergistic effect only with a low methadone dose. Escitalopram, reboxetine and venlafaxine given separately, each at a fixed subthreshold dose, induced no interaction. Possible clinical implications of these findings are that while escitalopram, reboxetine and venlafaxine do not affect methadone's antinociception in mice and are safe to be given together with methadone when indicated, fluvoxamine, clomipramine and desipramine considerably augment methadone-induced effects and should be avoided in this population due to the risk of inducing opiate overdose. For the chromic experiment, when a subthreshold dose of either escitalopram, desipramine or clomipramine was injected to mice following 2 weeks of methadone administration with the mini-pump, none of the antidepressant drugs strengthened methadone's analgesic effect. Further studies are needed before possible clinical implications can be drawn.
Similar articles
-
Interaction between methylphenidate, methadone and different antidepressant drugs on antinociception in mice, and possible clinical implications.World J Biol Psychiatry. 2017 Jun;18(4):300-307. doi: 10.3109/15622975.2015.1086492. Epub 2015 Nov 3. World J Biol Psychiatry. 2017. PMID: 26529542
-
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.J Pharmacol Exp Ther. 2001 Aug;298(2):581-91. J Pharmacol Exp Ther. 2001. PMID: 11454919
-
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.J Pharmacol Exp Ther. 2001 Aug;298(2):565-80. J Pharmacol Exp Ther. 2001. PMID: 11454918
-
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.Anesthesiology. 2011 Dec;115(6):1291-8. doi: 10.1097/ALN.0b013e31823940c0. Anesthesiology. 2011. PMID: 22037635 Review. No abstract available.
-
[Review of antidepressants from the TCAs to the third generation drugs].Neuropsychopharmacol Hung. 2004 Dec;6(4):185-94. Neuropsychopharmacol Hung. 2004. PMID: 15825674 Review. Hungarian.
Cited by
-
A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?Pharmaceuticals (Basel). 2025 Feb 3;18(2):208. doi: 10.3390/ph18020208. Pharmaceuticals (Basel). 2025. PMID: 40006022 Free PMC article.
-
Magnesium Salt, a Simple Strategy to Improve Methadone Analgesia in Chronic Pain: An Isobolographic Preclinical Study in Neuropathic Mice.Front Pharmacol. 2020 May 8;11:566. doi: 10.3389/fphar.2020.00566. eCollection 2020. Front Pharmacol. 2020. PMID: 32457607 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources